These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16766759)

  • 1. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population.
    Browning BL
    Gut; 2006 Jul; 55(7):1050; author reply 1050. PubMed ID: 16766759
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of DLG5 and inflammatory bowel disease across populations.
    Tenesa A; Noble C; Satsangi J; Dunlop M
    Eur J Hum Genet; 2006 Mar; 14(3):259-60; author reply 260-1. PubMed ID: 16391570
    [No Abstract]   [Full Text] [Related]  

  • 3. The R30Q DLG5 variant is not associated with celiac disease or inflammatory bowel disease in the Spanish population.
    Dema B; Fernández-Arquero M; Maluenda C; Polanco I; Figueredo MA; De La Concha EG; Urcelay E; Núñez C
    Tissue Antigens; 2011 Jan; 77(1):62-4. PubMed ID: 20796250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson N; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    J Pediatr; 2007 Mar; 150(3):268-73. PubMed ID: 17307543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the genetics of inflammatory bowel disease.
    Newman B; Siminovitch KA
    Curr Opin Gastroenterol; 2005 Jul; 21(4):401-7. PubMed ID: 15930978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.
    De Jager PL; Graham R; Farwell L; Sawcer S; Richardson A; Behrens TW; Compston A; Hafler DA; Kere J; Vyse TJ; Rioux JD
    Genes Immun; 2006 Jun; 7(4):327-34. PubMed ID: 16642031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
    Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, genes and inflammatory bowel diseases in childhood.
    de Mesquita MB; Civitelli F; Levine A
    Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DLG5 variants with gluten-sensitive enteropathy.
    Festen EA; Zhernakova A; Wijmenga C; Weersma RK
    Gut; 2008 Jul; 57(7):1027-8. PubMed ID: 18559397
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease.
    Li Y; Chen P; Sun J; Huang J; Tie H; Li L; Li H; Ren G
    Sci Rep; 2016 Sep; 6():33550. PubMed ID: 27633114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission ratio distortion of DLG5 R30Q: evidence for prenatal selection?
    Henckaerts L; Vlietinck R; Derom C; Boonen S; Rutgeerts P; Vermeire S
    Inflamm Bowel Dis; 2010 Jun; 16(6):910-1. PubMed ID: 19774648
    [No Abstract]   [Full Text] [Related]  

  • 15. DLG5 and OCTN.
    Vermeire S
    Inflamm Bowel Dis; 2004 Nov; 10(6):888-90. PubMed ID: 15626909
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease.
    Chua KH; Lian LH; Kee BP; Thum CM; Lee WS; Hilmi I; Goh KL
    J Dig Dis; 2011 Dec; 12(6):459-66. PubMed ID: 22118696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
    Biank V; Friedrichs F; Babusukumar U; Wang T; Stoll M; Broeckel U; Kugathasan S
    Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.
    Medici V; Mascheretti S; Croucher PJ; Stoll M; Hampe J; Grebe J; Sturniolo GC; Solberg C; Jahnsen J; Moum B; Schreiber S; Vatn MH
    Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of discs large homolog 5.
    Friedrichs F; Stoll M
    World J Gastroenterol; 2006 Jun; 12(23):3651-6. PubMed ID: 16773680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men.
    Lin Z; Poritz L; Franke A; Li TY; Ruether A; Byrnes KA; Wang Y; Gebhard AW; MacNeill C; Thomas NJ; Wu R; Schreiber S; Koltun WA
    Dis Markers; 2009; 27(5):193-201. PubMed ID: 20037206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.